Intelligence Platform

Patents

Browse 77 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 11844764

Agitation process for preparing a carbetocin drug product

ACADIA Pharmaceuticals Inc. · Granted Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11827600

Crystalline forms of trofinetide

ACADIA Pharmaceuticals Inc. · Granted Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11464768

Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psych

ACADIA Pharmaceuticals Inc. · Granted Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11452721

Formulations of pimavanserin

ACADIA Pharmaceuticals Inc. · Granted Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11191757

Combination of pimavanserin and cytochrome P450 modulators

ACADIA Pharmaceuticals Inc. · Granted Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11161826

Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent

ACADIA Pharmaceuticals Inc. · Granted Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11135211

Pimavanserin for treating impulse control disorder

ACADIA Pharmaceuticals Inc. · Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11091473

Compounds for pain treatment, compositions comprising same, and methods of using same

ACADIA Pharmaceuticals Inc. · Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10953000

Combination of pimavanserin and cytochrome P450 modulators

ACADIA Pharmaceuticals Inc. · Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10849891

Formulations of pimavanserin

ACADIA Pharmaceuticals Inc. · Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10646480

Formulations of pimavanserin

ACADIA Pharmaceuticals Inc. · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10525046

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10517860

Combination of pimavanserin and cytochrome P450 modulators

ACADIA Pharmaceuticals Inc. · Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10449185

Formulations of pimavanserin

ACADIA Pharmaceuticals Inc. · Granted Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10028944

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9765053

Methods of treatment using selective 5-HT2A inverse agonists

ACADIA Pharmaceuticals Inc. · Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9757366

Methods for the treatment of parkinson's disease psychosis using pimavanserin

ACADIA Pharmaceuticals Inc. · Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9670209

Muscarinic agonists

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9566271

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9522906

Tetrahydroquinoline analogues as muscarinic agonists

ACADIA Pharmaceuticals Inc. · Granted Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9446037

Methods for the treatment of parkinson's disease psychosis using pimavanserin

ACADIA Pharmaceuticals Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9296694

Azacyclic compounds

ACADIA Pharmaceuticals Inc. · Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9211289

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative

ACADIA Pharmaceuticals Inc. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9061981

Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen recepto

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted